Medical Devices Investors & VC Firms in Asia-Pacific
420 firms in this list, with a median first check of $500K. 82 of them lead rounds. Generated from verified public data and updated continuously.
Remiges Ventures, Inc.
SeattleSeed
21 people
Monograph Capital Partners
LondonSeed–Series B
21 people
Taihill Venture
CambridgePre-Seed–Seed
11 people
Taiwan Global Angels
BerkeleyPre-Seed–Series B$300K – $3M
19 people
Nordic Capital
StockholmGrowth–Late Stage
12 people
Brookstreet Equity Partners
LondonSeries A–Late Stage
22 people
Delos Capital
CambridgeSeed–Growth
13 people
Eaton Square
LondonSeries A–Growth
25 people
HBM Partners
ZugSeed–Late Stage$5M – $50M
6 people
Pappas Capital
Research Triangle ParkSeed–Late Stage$100K – $6M
15 people
MBX Capital
ClaymontPre-Seed–Series A$250K – $2.5M
5 people
Ally Bridge Group
New YorkGrowth–Late Stage
7 people
Applied Ventures
Santa ClaraSeed–Series A$500K – $3M
16 people
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Growth$16.2M
16 people
H.I.G. HealthBridge Partners
MiamiGrowth$5M – $40M
12 people
Newton Biocapital
BrusselsSeed–Series A
16 people
Scientia Ventures
New YorkSeries A–Series B
13 people
Raisewell Ventures
San FranciscoPre-Seed–Series B
19 people
6 Dimensions Capital
Grand CaymanSeed–Late Stage
17 people
Apex Innovative Investments Ventures
VancouverPre-Seed–Seed$250K
9 people
Revere Partners
Seed–Series B
15 people
Prana Tech Ventures
MetuchenPre-Seed–Seed
12 people
3B Future Health Fund
MonacoPre-Seed–Series A$12M
11 people
Redesign Health
New YorkSeed–Late Stage
13 people
Related lists
Investors & VC Firms in North America (12835)Investors & VC Firms in United States (11883)Investors & VC Firms in Europe (5830)Investors & VC Firms in Global (4736)AI & Machine Learning Investors & VC Firms (4564)Fintech Investors & VC Firms (4546)SaaS Investors & VC Firms (4222)Healthtech Investors & VC Firms (4190)Enterprise Software Investors & VC Firms (4099)Crypto & Web3 Investors & VC Firms (3974)
Data sourced from public filings and firms' own websites — see our methodology.






































































































